iRhythm Technologies reported strong Q2 results with revenue up 20.1% to $224.2 million and earnings of $0.58 per share, beating expectations. Profitability improved with a gross margin of 72.8% and adjusted EBITDA of $43.3 million. Following this, Truist Financial raised the price target from $160 to $168, indicating a 35.35% upside. The company also raised its full-year revenue guidance and plans to acquire VitalConnect to expand its patient-monitoring product range.
Insight Enterprises reported impressive Q2 results with earnings per share of $3.86, beating estimates by nearly 31%, and revenue of $2.40 billion, up 15% year-over-year. Gross profit increased by 18%, prompting the company to raise its full-year fin...
Tesla delivered a record 480,126 vehicles and generated $28.24 billion in revenue but missed earnings expectations with a non-GAAP EPS of $0.33, 38.51% below forecasts. The company faced financial pressures including a negative free cash flow of $1.0...
Caledonia Mining Corporation Plc reported a strong Q2 2026 earnings per share of $1.36, far exceeding analyst estimates of $0.54. This was driven by an 18% increase in gold production at its Blanket Mine and a 34% rise in the realized gold price, boo...
Heron Therapeutics reported a Q2 loss per share of -$0.03, missing analyst expectations of -$0.02, with revenue of $37.67 million falling short of the $42.19 million estimate. Despite 44% growth in its acute-care franchise, slower expansion of key pr...
Teleflex reported Q2 revenue of $570.3 million, driven by its Vascular and Surgical segments, with adjusted EPS up 1.7% to $1.76. The company is selling its Acute Care, Interventional Urology, and OEM businesses for about $2.03 billion in cash to red...
